Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2010 Feb;11(2):108-9.
doi: 10.1016/S1470-2045(09)70400-0.

Immunity unleashed in melanoma

Michael K Erdmann
Comment

Immunity unleashed in melanoma

Michael K Erdmann. Lancet Oncol. 2010 Feb.
No abstract available

PubMed Disclaimer

Comment on

Similar articles

See all similar articles

Cited by

  • Trial Watch: Peptide-based anticancer vaccines.
    Pol J, Bloy N, Buqué A, Eggermont A, Cremer I, Sautès-Fridman C, Galon J, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Pol J, et al. Oncoimmunology. 2015 Jan 9;4(4):e974411. doi: 10.4161/2162402X.2014.974411. eCollection 2015 Apr. Oncoimmunology. 2015. PMID: 26137405 Free PMC article. Review.
  • Novel immune checkpoint blocker approved for the treatment of advanced melanoma.
    Galluzzi L, Kroemer G, Eggermont A. Galluzzi L, et al. Oncoimmunology. 2014 Dec 21;3(11):e967147. doi: 10.4161/21624011.2014.967147. eCollection 2014 Nov. Oncoimmunology. 2014. PMID: 25941597 Free PMC article. No abstract available.
  • Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications.
    Buqué A, Bloy N, Aranda F, Castoldi F, Eggermont A, Cremer I, Fridman WH, Fucikova J, Galon J, Marabelle A, Spisek R, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Buqué A, et al. Oncoimmunology. 2015 Mar 2;4(4):e1008814. doi: 10.1080/2162402X.2015.1008814. eCollection 2015 Apr. Oncoimmunology. 2015. PMID: 26137403 Free PMC article. Review.
  • Trial watch: Tumor-targeting monoclonal antibodies for oncological indications.
    Vacchelli E, Pol J, Bloy N, Eggermont A, Cremer I, Fridman WH, Galon J, Marabelle A, Kohrt H, Zitvogel L, Kroemer G, Galluzzi L. Vacchelli E, et al. Oncoimmunology. 2015 Feb 3;4(1):e985940. doi: 10.4161/2162402X.2014.985940. eCollection 2015 Jan. Oncoimmunology. 2015. PMID: 25949870 Free PMC article. Review.
  • Classification of current anticancer immunotherapies.
    Galluzzi L, Vacchelli E, Bravo-San Pedro JM, Buqué A, Senovilla L, Baracco EE, Bloy N, Castoldi F, Abastado JP, Agostinis P, Apte RN, Aranda F, Ayyoub M, Beckhove P, Blay JY, Bracci L, Caignard A, Castelli C, Cavallo F, Celis E, Cerundolo V, Clayton A, Colombo MP, Coussens L, Dhodapkar MV, Eggermont AM, Fearon DT, Fridman WH, Fučíková J, Gabrilovich DI, Galon J, Garg A, Ghiringhelli F, Giaccone G, Gilboa E, Gnjatic S, Hoos A, Hosmalin A, Jäger D, Kalinski P, Kärre K, Kepp O, Kiessling R, Kirkwood JM, Klein E, Knuth A, Lewis CE, Liblau R, Lotze MT, Lugli E, Mach JP, Mattei F, Mavilio D, Melero I, Melief CJ, Mittendorf EA, Moretta L, Odunsi A, Okada H, Palucka AK, Peter ME, Pienta KJ, Porgador A, Prendergast GC, Rabinovich GA, Restifo NP, Rizvi N, Sautès-Fridman C, Schreiber H, Seliger B, Shiku H, Silva-Santos B, Smyth MJ, Speiser DE, Spisek R, Srivastava PK, Talmadge JE, Tartour E, Van Der Burg SH, Van Den Eynde BJ, Vile R, Wagner H, Weber JS, Whiteside TL, Wolchok JD, Zitvogel L, Zou W, Kroemer G. Galluzzi L, et al. Oncotarget. 2014 Dec 30;5(24):12472-508. doi: 10.18632/oncotarget.2998. Oncotarget. 2014. PMID: 25537519 Free PMC article. Review.

MeSH terms

LinkOut - more resources